The capacity of CD38-specific BARs to induce antibody-dependent cellular cytotoxicity (ADCC) was evaluated using Daudi luc, CA-46 luc, and LP-1 luc tumor cell lines as targets and hCD16-transduced NK92 cells as effectors (Fig. 4). The gene discussed is CD38; the disease is neoplasm.